Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Insufficiency,Type 2 Diabetes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT04858854
What this trial is testing

Effect of Broccoli Sprout Extract in Patients With Chronic Kidney Disease With Diabetes Type 2

Who this might be right for
Chronic Kidney Disease Stage 3BChronic Kidney Disease stage4Diabetes Mellitus, Type 2
Karolinska Institutet 100
Large-scale testing (Phase 3)Ended earlyNCT00958269
What this trial is testing

Study to Evaluate Safety and Efficacy of Dutogliptin in Type 2 Diabetes Mellitus Subjects With Moderate and Severe Renal Impairment

Who this might be right for
Type 2 Diabetes MellitusRenal Impairment
Phenomix 360
Not applicableUnknownNCT03330054
What this trial is testing

Frequency Of Eye Problems In Type 2 Diabetes With Chronic Kidney Disease

Who this might be right for
Eye DiseasesRenal ImpairmentType2 Diabetes
Mohammed Ramadan Abdallah 100
Not applicableActive Not RecruitingNCT07348718
What this trial is testing

Rubix LS Diabetic Kidney Disease (DKD) Registry Study

Who this might be right for
Diabetic Kidney Disease (DKD)
Rubix LS 2,000
Early research (Phase 1)Study completedNCT01069926
What this trial is testing

To Assess the Pharmacokinetics of AZD1656 and Its Metabolite in Type 2 Diabetes Mellitus Patients

Who this might be right for
Glucose Lowering
AstraZeneca 21
Not applicableStudy completedNCT05640180
What this trial is testing

An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Bayer 17,847
Testing effectiveness (Phase 2)Study completedNCT05536804
What this trial is testing

Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Who this might be right for
OverweightObesityChronic Kidney Disease+2 more
Eli Lilly and Company 134
Not applicableActive Not RecruitingNCT01047735
What this trial is testing

The TRIABETES - ARMMS-T2D Study: A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusObesity
University of Pittsburgh 69
Not applicableLooking for participantsNCT07434791
What this trial is testing

Goal-Directed Therapy to Reduce Kidney and Cardiovascular Risk in Diabetic Kidney Disease (GOLD-STANDARD)

Who this might be right for
Diabetic Kidney Disease (DKD)Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease
Sunnybrook Health Sciences Centre 100
Not applicableLooking for participantsNCT06838416
What this trial is testing

Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney DiseaseRenal Function
Second Affiliated Hospital of Soochow University 300
Not applicableLooking for participantsNCT05881447
What this trial is testing

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

Who this might be right for
Chronic Kidney DiseasesType 2 Diabetes MellitusArterial Hypertension+8 more
Swiss Tropical & Public Health Institute 1,200
Not applicableStudy completedNCT07818434
What this trial is testing

Prevalence of Renal Insufficiency in Patients With Type 2 Diabetes : A Retrospective Study.

Who this might be right for
Diabetic Kidney Disease
India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals 12,000
Not applicableStudy completedNCT02917057
What this trial is testing

Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment

Who this might be right for
Type 2 Diabetes
AstraZeneca 6,024
Post-approval studies (Phase 4)Not Yet RecruitingNCT07116928
What this trial is testing

Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)CKD - Chronic Kidney Disease
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 1,244
Not applicableStudy completedNCT04361097
What this trial is testing

Fecal Microbiota Transplantation as a Therapeutic Strategy in the Progression of Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Due to HypertensionChronic Kidney Disease Due to Type 2 Diabetes Mellitus
Hospital Universitario Dr. Jose E. Gonzalez 28
Not applicableUnknownNCT04998461
What this trial is testing

Impact of Obesity, Chronic Kidney Disease and Type 2 Diabetes on Human Urinary Stem Cells

Who this might be right for
Chronic Kidney DiseasesObesityStem Cells+1 more
Hospices Civils de Lyon 60
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Large-scale testing (Phase 3)Study completedNCT03242018
What this trial is testing

Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control

Who this might be right for
Type 2 Diabetes MellitusChronic Kidney Disease Stage 4
Lexicon Pharmaceuticals 277
Post-approval studies (Phase 4)Study completedNCT02964585
What this trial is testing

Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
George Washington University 34
Large-scale testing (Phase 3)Active Not RecruitingNCT06297603
What this trial is testing

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 320
Next Page